Hu Jun-Nan, Xu Xing-Yue, Li Wei, Wang Yi-Ming, Liu Ying, Wang Zi, Wang Ying-Ping
College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, China.
Institute of Special Wild Economic Animals and Plant, CAAS, Changchun, China.
J Ginseng Res. 2019 Jan;43(1):10-19. doi: 10.1016/j.jgr.2017.07.003. Epub 2017 Jul 25.
Frequent overdose of paracetamol (APAP) has become the major cause of acute liver injury. The present study was designed to evaluate the potential protective effects of ginsenoside Rk1 on APAP-induced hepatotoxicity and investigate the underlying mechanisms for the first time.
Mice were treated with Rk1 (10 mg/kg or 20 mg/kg) by oral gavage once per d for 7 d. On the 7th d, all mice treated with 250 mg/kg APAP exhibited severe liver injury after 24 h, and hepatotoxicity was assessed.
Our results showed that pretreatment with Rk1 significantly decreased the levels of serum alanine aminotransferase, aspartate aminotransferase, tumor necrosis factor, and interleukin-1β compared with the APAP group. Meanwhile, hepatic antioxidants, including superoxide dismutase and glutathione, were elevated compared with the APAP group. In contrast, a significant decrease in levels of the lipid peroxidation product malondialdehyde was observed in the ginsenoside Rk1-treated group compared with the APAP group. These effects were associated with a significant increase of cytochrome P450 E1 and 4-hydroxynonenal levels in liver tissues. Moreover, ginsenoside Rk1 supplementation suppressed activation of apoptotic pathways by increasing Bcl-2 and decreasing Bax protein expression levels, which was shown using western blotting analysis. Histopathological observation also revealed that ginsenoside Rk1 pretreatment significantly reversed APAP-induced necrosis and inflammatory infiltration in liver tissues. Biological indicators of nitrative stress, such as 3-nitrotyrosine, were also inhibited after pretreatment with Rk1 compared with the APAP group.
The results clearly suggest that the underlying molecular mechanisms in the hepatoprotection of ginsenoside Rk1 in APAP-induced hepatotoxicity may be due to its antioxidation, antiapoptosis, anti-inflammation, and antinitrative effects.
对乙酰氨基酚(APAP)频繁过量服用已成为急性肝损伤的主要原因。本研究旨在首次评估人参皂苷Rk1对APAP诱导的肝毒性的潜在保护作用,并探究其潜在机制。
小鼠每天经口灌胃给予Rk1(10毫克/千克或20毫克/千克),持续7天。在第7天,所有用250毫克/千克APAP处理的小鼠在24小时后均表现出严重肝损伤,并对肝毒性进行评估。
我们的结果表明,与APAP组相比,Rk1预处理显著降低了血清丙氨酸转氨酶、天冬氨酸转氨酶、肿瘤坏死因子和白细胞介素-1β的水平。同时,与APAP组相比,包括超氧化物歧化酶和谷胱甘肽在内的肝脏抗氧化剂水平升高。相比之下,与APAP组相比,人参皂苷Rk1处理组的脂质过氧化产物丙二醛水平显著降低。这些作用与肝组织中细胞色素P450 E1和4-羟基壬烯醛水平的显著升高有关。此外,使用蛋白质免疫印迹分析表明,补充人参皂苷Rk1通过增加Bcl-2和降低Bax蛋白表达水平来抑制凋亡途径的激活。组织病理学观察还显示,人参皂苷Rk1预处理显著逆转了APAP诱导的肝组织坏死和炎症浸润。与APAP组相比,用Rk1预处理后,诸如3-硝基酪氨酸等硝化应激的生物学指标也受到抑制。
结果清楚地表明,人参皂苷Rk1对APAP诱导的肝毒性具有肝保护作用的潜在分子机制可能是由于其抗氧化、抗凋亡、抗炎和抗硝化作用。